health
Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU) - Regeneron Pharmaceuticals (NASDAQ:REGN)
Sanofi Eyes Even Bigger Market for Blockbuster Asthma Drug
By Ashleigh FurlongYour Daily FoodScope for September 11, 2024
Imperial Beach Sewage crisis causing fears of long-term illnesses
By Tony ShinSick and suicidal children held in Queensland police watch houses for weeks without healthcare, watchdog reveals
Nurses Spreading Misinformation : AJN The American Journal of Nursing
Bridge Fire in Angeles National Forest explodes to 34,000 acres
Chronquiry: How can students access health care on campus?
Analyzing suicide trends across Wisconsin and ways to prevent it
When a server accidentally served a $5,750 bottle of wine her manager told the world about it